Australia's most trusted source of pharma news
Friday, 14 December 2018
Lost Your Access?
Sigma rockets on merger news
API's $727m pitch drives 45% spike in share price.
CSL launches new R&D hub
Will double scientist numbers in $46 million Bio21 expansion.
Pfizer beats GSK to NIP
Nimenrix to be given to teenagers next April
Bispecifics - the next big thing?
Find out why big pharma is so excited about bispecifics.
Pill Hill gets innovation cafe
Venture Cafe to be established in Macquarie Park.
Novartis adopts denim code
Aust president says jeans 'un-boss' company culture.
Roche names new GM
Portuguese head flying in to replace Petersen in Aust.
New bosses for Roche, Gilead
Global CEOs shuffle as Roche boss heads over to Gilead.
Pfizer arrives at CBD home
First day in new offices marks a fresh start.
Thirty new drugs await 2019
Which pipeline products will hit the ARTG next year?
Hemlibra races to first-line
TGA expands use of potential Roche blockbuster.
Health retires HTA panel
Out with the old and in with the new in 2019.
Top 10 stories of 2018
Which stories attracted the greatest readership this year?
Roche, MSD lung battle ahead
Tecentriq submitted to TGA for expanded indication.
Roche's lung cancer win
Tecentriq, Avastin combo approved under priority review.
Embrace your inner millennial
Younger workers provide valuable insights on balance.
GP adds to GORD options
Generic Partners registers new PPI brands.
Events & Conferences
© 2003 - 2018 Lush Media
Pharma in Focus
Jolly Good Design